|
Anti
Retrovirals Market The Battle Continues
As the spread of HIV in India continues unabated, drug manufacturers
search for innovative second line treatments.
Arshiya Khan does a status check on the anti retrovirals market
Lupin
Acquires Rubamin Labs
Lupin has announced the acquisition of Rubamin Laboratories
(RLL), the pharmaceuticals arm of the Rubamin Group, for an
undisclosed amount.
Flamingo
to double capacity
Flamingo Pharmaceuticals has announced its plans to double
its capacity at an investment of Rs 100 crore to establish
its strong presence in the domestic market and leveraging
the export opportunity in the contract manufacturing business.
Sanofi-Aventis
receives FDA nod for Taxotere
Sanofi-Aventis announ-ced that the FDA has approved Taxotere
injection concentrate in combination with cisplatin and 5-fluorouracil
for induction therapy of locally advanced squamous cell carcinoma
of the head and neck before patients undergoing chemo radiotherapy
and surgery.
Glenmark
receives MHRA approval for Baddi plant
Glenmark Pharmaceuticals has received approval from MHRA of
UK for its state of the art semi-solids (ointments & creams)
manufacturing plant at Baddi, Himachal Pradesh.
Caraco
gets USFDA nod for Methimazole
Caraco Pharmaceutical Laboratories, a subsidiary of Sun Pharma,
has announced that the US Food and Drug Administration (FDA)
has granted final approval for the company's ANDA for Methimazole
Tablets USP in 5 mg and 10 mg doses.
US
FDA nod for Glenmark and Sun's generic Trileptal
Glenmark Pharmaceuticals and Sun Pharma have received final
approval from the USFDA for marketing the first generic
version of Trileptal (Oxcarbazepine) tablets in three strengths
of 150 mg, 300 mg and 600 mg.
Hepatoprotective
nimesulide awaits patent rights
Ahmedabad based Lincoln Pharmaceuticals has launched hepatoproctive
Nimesulide with the brand name of Namsafe. Nimesulide is well
accepted in NSAID and by the medical fraternity.
GVK
BIO inaugurates new Research Center
GVK Biosciences inaugurated the GVK BIO Wyeth Hyderabad Chemistry
Center, a built-to-suit research centre for Wyeth Pharmaceuticals
located in Hyderabad.
'Government
should allow industry to generate more profit'
Homi Bhabha, Director, Organisation of Pharmaceutical Producers
of India (OPPI) share his views on pharma pricing policies
with Arshiya Khan
Time
to dust the carpet
The Indian Drug Manufacturers' Association (IDMA) organized
a symposium on 'Spurious Drugs Menace: Realities & Remedies
in Mumbai. Nandini Patwardhan reports
Indian
pharma uses CPhI Worldwide as springboard for success
Indian pharma reinforced its global ambitions in no uncertain
terms at the recently concluded CPhI Worldwide exhibition
in Milan, Italy. Viveka Roychowdhury reports
Upcoming
Events
Analytica
Anacon India 2007 focusses on Hyderabad
After Mumbai and Bangalore, the fourth edition of Analytica
Anacon India 2007 shifts its focus to Hyderabad, the fastest
growing pharma destination in India.
CMP
India brings a three-in-one advantage to Mumbai
Pharmaceutical professionals from all over the world will
be gathering in Mumbai this November, for South Asia's biggest
and most comprehensive pharmaceutical exhibition.
|
